USANA BiOmega Earns ConsumerLab Seal of Approval for Quality and Purity

USANA’s BiOmega supplement earns renewed ConsumerLab approval for quality and label accuracy.

What the company is saying

USANA Health Sciences (NYSE:USNA) is highlighting that its BiOmega omega-3 supplement has again received the ConsumerLab Seal of Approval, underscoring independent validation of product quality, purity, and label accuracy. The company voluntarily submitted BiOmega to ConsumerLab’s Quality Certification Program, where it underwent the same testing as other omega-3 products in the 2026 Fish Oil, Krill Oil, and Algal Oil Omega-3 Supplements Review. USANA emphasizes its longstanding commitment to quality, referencing more than 30 years in the industry and a track record of independent recognition. Chief scientific officer Dr. Kathryn Armstrong and chief commercial officer Brent Neidig are quoted to reinforce the company’s focus on rigorous internal and third-party testing. The announcement also notes that BiOmega is one of seven USANA products currently approved by ConsumerLab, spanning several supplement categories. The company details its FDA-registered, GMP-certified manufacturing facility and internal batch testing protocols, positioning third-party validation as an additional layer of consumer confidence.

What the data suggests

The only quantitative disclosures are that BiOmega is one of seven USANA products currently approved by ConsumerLab and that USANA has operated for more than 30 years, with products trusted in over 25 countries. BiOmega passed ConsumerLab’s 2026 omega-3 review, which found differences among products in EPA and DHA concentration and freshness, but BiOmega met all quality standards. The product previously earned the Seal of Approval in 2016, when testing confirmed it contained 100 percent of its claimed EPA, DHA, and total omega-3s, and met standards for lead, arsenic, cadmium, and mercury. No batch-level data, sales figures, or financial metrics are disclosed. The announcement demonstrates that BiOmega meets independent quality benchmarks, but provides no evidence of financial impact, market share, or sales growth resulting from this certification. The claims regarding health benefits of EPA and DHA are not substantiated with clinical or numerical evidence in this disclosure.

Analysis

The announcement is factual and focused on the recent achievement of the ConsumerLab Seal of Approval for USANA's BiOmega supplement. All key claims are realised and supported by the disclosed facts, such as the product passing independent testing and being one of seven USANA products currently approved by ConsumerLab. There are no forward-looking projections, exaggerated growth claims, or aspirational statements about future financial or operational performance. The language is positive but proportionate to the evidence, with no inflation of the significance of the certification. No large capital outlay or delayed benefit is disclosed. The absence of financial metrics is not a deficiency here, as the announcement is a product quality update and not an earnings or operational results release.

Risk flags

• ●The announcement provides no financial data or sales figures, making it impossible to assess whether third-party certification translates into increased revenue or market share. This limits the ability to gauge the material impact of the certification on company performance.
• ●Claims about product health benefits and rigorous internal testing are not supported by disclosed clinical trial data, batch pass rates, or specific quality metrics. This creates a gap between the narrative of scientific rigor and the evidence presented.
• ●The focus on third-party certification and reputation may distract from underlying business fundamentals if not accompanied by financial or operational disclosures in future updates.

Bottom line

USANA’s renewed ConsumerLab Seal of Approval for BiOmega reinforces its positioning as a quality-focused supplement provider, with independent validation supporting its claims of product purity and label accuracy. The announcement is credible in its quality narrative but does not provide any evidence of financial benefit, sales growth, or market impact resulting from the certification. Investors receive assurance of product standards but no insight into whether this translates into improved business performance. The most important takeaway is that USANA continues to meet recognized third-party quality benchmarks, but the investment case would require disclosure of how such certifications affect sales, margins, or competitive positioning. Future updates should include financial or operational data to make the quality narrative actionable for investors.

Announcement summary

(NYSE:USNA) USANA Health Sciences announced that its BiOmega omega-3 supplement has earned the ConsumerLab Seal of Approval, providing independent validation of the company's commitment to product quality, purity, and label accuracy. USANA voluntarily submitted BiOmega to ConsumerLab's Quality Certification Program, where it underwent the same testing as other omega-3 products reviewed in ConsumerLab's 2026 Fish Oil, Krill Oil, and Algal Oil Omega-3 Supplements Review. BiOmega passed ConsumerLab's testing and earned the Seal of Approval. Dr. Kathryn Armstrong, chief scientific officer at USANA Health Sciences, stated that independent testing helps validate the company's quality standards. BiOmega is described as a potent fish oil concentrate fortified with vitamin D and formulated with EPA and DHA, two long-chain omega-3 fatty acids. ConsumerLab's 2026 omega-3 review found differences among products in EPA and DHA concentration and freshness, but BiOmega met the required quality standards. Brent Neidig, chief commercial officer at USANA, emphasized that quality has been a priority at USANA for more than 30 years. BiOmega is one of seven USANA products currently approved by ConsumerLab through its Quality Certification Program, with other approved products spanning omega-3s, multivitamins and minerals, probiotics, vitamin D, and protein. USANA manufactures its nutritional supplements in an FDA-registered, GMP-certified facility in Salt Lake City, and each batch is tested to meet the company's standards for quality, purity, and potency. The company combines internal testing with continued investment in research, state-of-the-art manufacturing, and gold-standard testing protocols. BiOmega has a history of earning independent recognition from ConsumerLab, including in 2016 when it earned the Seal of Approval after testing confirmed it contained 100 percent of its claimed amounts of EPA, DHA, and total omega-3s, and met quality levels for lead, arsenic, cadmium, and mercury. USANA has been providing premium-quality nutrition and lifestyle products for more than 30 years. The company’s products are trusted by elite athletes, Olympians, and health-conscious consumers in more than 25 countries worldwide.

Disagree with this article?